Part Three References

  1. Addington, A. M., & Rapoport, J. L. (2012). Annual research review: Impact of advances in genetics in understanding developmental psychopathology. Journal of Child Psychology and Psychiatry, 53, 510–518.
  2. American Psychiatric Association. (2004). Practice guideline for the treatment of patients with schizophrenia (2nd ed.). Retrieved from http://psychiatryonline.org/content.aspx?bookid=28&sectionid=1665359
  3. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: Author.
  4. Bajenaru, O., Tiu, C., Antochi, A., & Roceanu, A. (2012). Neurocognitive disorders in DSM 5 project: Personal comments. Journal of Neurological Sciences, 322, 17–19.
  5. Barrio Minton, C. A., & Prosek, E. (in press). Schizophrenia spectrum and other psychotic disorders. In V. E. Kress & M. Paylo (Eds.), Treating mental disorders: A strength-based, comprehensive approach to case conceptualization and treatment planning. Upper Saddle River, NJ: Pearson.
  6. Barton, M. L., Robins, D. L., Jashar, D., Brennan, L., & Fein, D. (2013). Sensitivity and specificity of proposed autism spectrum disorder in toddlers. Journal of Autism Development Disorder, 43, 1184–1195.
  7. Beck, A. T., Rector, N. A., Stolar, N., & Grant, P. (2009). Schizophrenia: Cognitive theory, research, and therapy. New York, NY: Guilford Press.
  8. Blazer, D. (2013). Neurocognitive disorders in DSM-5. American Journal of Psychiatry, 170, 585–587.
  9. Brand, B. L. (2012). What we know and what we need to learn about the treatment of dissociative disorders. Journal of Trauma & Dissociation, 13, 387–396. doi:10.1080/15299732.2012.672550
  10. Brand, B. L., Lanius, R., Vermetten, E., Loewenstein, R. J., & Spiegel, D. (2012). Where are we going? An update on assessment, treatment, and neurobiological research in dissociative disorders as we move toward the DSM-5. Journal of Trauma & Dissociation, 13, 9–31. doi:10.1080/15299732.2011.620687
  11. Brown, R. J., & Lewis-Fernández, R. (2011). Culture and conversion disorder: Implications for DSM-5. Psychiatry, 74, 187–206.
  12. Casecade, E., Kalali, A. H., & Buckley, P. (2009). Treatment of schizoaffective disorder. Psychiatry (Edgmont), 6, 15–17.
  13. Centers for Disease Control and Prevention. (2012). Prevalence of autism spectrum disorders: Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. Morbidity and Mortality Weekly Report, 61(3), 1–19.
  14. Cloitre, M., Courtois, C. A., Ford, J. D., Green, B. L., Alexander, P., Briere, J., . . . Van der Hart, O. (2012). The ISTSS expert consensus treatment guidelines for complex PTSD in adults. Retrieved from http://www.istss.org/AM/Template.cfm?Section=ISTSS_Complex_PTSD_Treatment_Guidelines&Template=/CM/ContentDisplay.cfm&ContentID=5185
  15. Coolidge, F. L., Marle, P. D., Rhoades, C. S., Monaghan, P., & Segal, D. L. (2013). Psychometric properties of a new measure to assess autism spectrum disorder in DSM-5. American Journal of Orthopsychiatry, 83, 126–130.
  16. Dimsdale, J. E. (2013). Somatic symptom disorder: An important change in DSM. Journal of Psychosomatic Research, 75, 223–228.
  17. Eriksen, K., & Kress, V. E. (2005). Beyond the DSM story: Ethical quandaries, challenges, and best practices. Thousand Oaks, CA: Sage.
  18. Fombonne, E. (2005). Epidemiology of autistic disorder and other pervasive developmental disorders. Journal of Clinical Psychiatry, 36, 272–281.
  19. Foote, B., Smolin, Y., Kaplan, M., Legatt, M. E., & Lipschitz, D. (2006). Prevalence of dissociative disorders in psychiatric outpatients. American Journal of Psychiatry, 163, 623–629.
  20. Frances, A., & Chapman, S. (2013). DSM-5 somatic symptom disorder mislabels medical illness as mental disorder. Australian & New Zealand Journal of Psychiatry, 47, 483–489. doi:10.1177/0004867413484525
  21. Frazier, T. W., Youngstrom, E. A., Speer, L., Embacher, R., Law, P., Constantino, J., . . . Eng, C. (2012). Validation of proposed DSM-5 criteria for autism spectrum disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 51, 28–40.
  22. Gaebel, W. (2011). Schizophrenia: Current science and clinical practice. Hoboken, NJ: Wiley-Blackwell.
  23. Gaebel, W., Zielasek, J., & Cleveland, H. (2012). Classifying psychosis: Challenges and opportunities. International Review of Psychiatry, 24, 538–548. doi:10.3109/09540261.2012.737313
  24. Ganguli, M., Blacker, D., Blazer, D., Grant, I., Jeste, D. V., Paulson, J. S., . . . Perminder, S. S. (2011). Classification of neurocognitive disorders in DSM-5: A work in progress. American Journal of Geriatric Psychiatry, 19, 205–210.
  25. Gearing, R. E. (2008). Evidence-based family psychoeducational interventions for children and adolescents with psychotic disorders. Journal of Canadian Academy of Child and Adolescent Psychiatry, 17, 2–11.
  26. Gearing, R. E., & Mian, I. (2009). The role of gender in early and very early onset of psychotic disorders. Clinical Schizophrenia & Related Psychoses, 2, 298–306.
  27. Geda, Y. E., & Nedelska, Z. (2012). Mild cognitive impairment: A subset of mild neurocognitive disorder? American Journal of Geriatric Psychiatry, 20, 821–827.
  28. Ghanizadeh, A. (2013). Agreement between Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition and the proposed DSM-V attention deficit hyperactivity disorder diagnostic criteria: An exploratory study. Comprehensive Psychiatry, 54, 7–10.
  29. Gibbs, V., Aldridge, F., Chandler, F., Witzlsperger, E., & Smith, K. (2012). Brief report: An exploratory study comparing diagnostic outcomes for autism spectrum disorders under DSM-IV-TR with the proposed DSM-5 revision. Journal of Autism and Developmental Disorders, 42, 1750–1756.
  30. Greaves-Lord, K., Eussen, M. L., Verhulst, F. C., Minderaa, R. B., Mandy, W., Hudziak, J. J., . . . Hartman, C. A. (2013). Empirically based phenotypic profiles of children with pervasive developmental disorders: Interpretation in the light of the DSM-5. Journal of Autism and Developmental Disorders, 43, 1784–1797.
  31. Gupta, M. (2013). Review of somatic symptoms in post-traumatic stress disorder. International Review of Psychiatry, 25, 86–99. doi:10.3109/09540261.2012.736367
  32. Hassan, I., & Ali, R. (2011). The association between somatic symptoms, anxiety disorders and substance use: A literature review. Psychiatry Quarterly, 82, 315–328.
  33. Heckers, S. (2012). Diagnostic criteria for schizoaffective disorder. Expert Reviews Neurotherapeutics, 12, 1–3. doi:10.1586/ERN.11.179
  34. Helldin, L., Kane, J. M., Karilampi, U., Norlander, T., & Archer, T. (2007). Remission in prognosis of functional outcome: A new dimension in the treatment of patients with psychotic disorders. Schizophrenia Research, 93, 160–168.
  35. Helseth, V., Lykke-Enger, T., Johnsen, J., & Waal, H. (2009). Substance use disorders among psychotic patients admitted to inpatient psychiatric care. Nordic Journal of Psychiatry, 63, 72–77.
  36. Horan, W. P., Harvy, P., Kern, R. S., & Green, M. F. (2011). Neurocognition, social cognition and functional outcome in schizophrenia. In W. Gaebel (Ed.), Schizophrenia: Current science and clinical practice (pp. 68–107). Hoboken, NJ: Wiley-Blackwell.
  37. Hurwitz, T. A. (2004). Somatization and conversion disorder. Canadian Journal of Psychiatry, 49, 172–178.
  38. International Society for the Study of Dissociation. (2004). Guidelines for the evaluation and treatment of dissociative symptoms in children and adolescents. Journal of Trauma & Dissociation, 5, 119–150. doi:10.1300/J229v05n03_09
  39. International Society for the Study of Trauma and Dissociation. (2011). Guidelines for treating dissociative identity disorder in adults, third revision. Journal of Trauma & Dissociation, 12, 115–187. doi:10.1080/15299732.2011.537247
  40. International Society for the Study of Trauma and Dissociation. (2013a). Child/adolescent FAQ's. Retrieved from http://www.isst-d.org/default.asp?contentID=100
  41. International Society for the Study of Trauma and Dissociation. (2013b). Dissociation FAQ's. Retrieved from http://www.isst-d.org/default.asp?contentID=76#diss
  42. Jolley, S., & Garety, P. (2011). Cognitive–behavioural interventions. In W. Gaebel (Ed.), Schizophrenia: Current science and clinical practice (pp. 185–215). Chichester, England: Wiley-Blackwell.
  43. Kantrowitz, J. T., & Citrome, L. (2011). Schizoaffective disorder: A review of current research themes and pharmacological management. CNS Drugs, 25, 317–331. doi:1172-7047/11/0004-0317
  44. Keller, W. R., Fischer, B. A., & Carpenter, W. T. (2011). Revisiting the diagnosis of schizophrenia: Where have we been and where are we going? CNS Neuroscience & Therapeutics, 17, 83–88. doi:10.1111/j.1755-5949.2010.00229.x
  45. Kingdon, D. G., & Turkington, D. (2002). Cognitive–behavioral therapy of schizophrenia. New York, NY: Guilford Press.
  46. Kopelowicz, A., Liberman, R. P., & Zarate, R. (2007). Psychosocial treatments for schizophrenia. In P. E. Nathan & J. M. Gorman (Ed.), A guide to treatments that work (pp. 243–269) New York, NY: Oxford University Press.
  47. Korzekwa, M. I., Dell, P. F., Links, P. S., Thabane, L., & Fougere, P. (2009). Dissociation in borderline personality disorder: A detailed look. Journal of Trauma and Dissociation, 10, 346–367. doi:10.1080/15299730902956838
  48. Kurita, H. (2011). How to deal with the transition from pervasive developmental disorders in DSM-IV to autism spectrum disorder in DSM-V. Psychiatry and Clinical Neurosciences, 65, 609–610.
  49. Lai, M.-C., Lombardo, M. V., Chakrabarti, B., & Baron-Cohen, S. (2013). Subgrouping the autism “spectrum”: Reflections on DSM-5. PLOS Biology, 11(4), 1–7.
  50. Lake, C. R., & Hurwitz, N. (2008). Schizoaffective disorder—its rise and fall: Perspectives for DSM-V. Clinical Schizophrenia & Related Psychoses, 2, 91–97.
  51. Lanius, R. A., Brand, B., Vermetten, E., Frewen, P. A., & Spiegel, D. (2012). The dissociative subtype of posttraumatic stress disorder: Rationale, clinical and neurobiological evidence, and implications. Depression and Anxiety, 29, 701–708. doi:10.1002/da.21889
  52. Lauritsen, M. B. (2013). Autism spectrum disorders. European Child and Adolescent Psychiatry, 22, S37–S42.
  53. Magariños, M., Zafar, U., Nissenson, K., & Blanco, C. (2002). Epidemiology and treatment of hypochondriasis. CNS Drugs, 16, 9–22.
  54. Mandy, W. P., Charman, T., Gilmour, J., & Skuse, D. H. (2011). Towards specifying pervasive developmental disorder-not otherwise specified. Autism Research, 4, 1–11.
  55. Mandy, W. P., Charman, T., & Skuse, D. H. (2012). Testing the construct validity of proposed criteria for DSM-5 autism spectrum disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 51, 41–50.
  56. Mayes, S. D., Black, A., & Tierney, C. D. (2013). DSM-5 under-identifies PDDNOS: Diagnostic agreement between the DSM-IV and Checklist for Autism Spectrum Disorder. Research in Autism Spectrum Disorders, 7, 298–306.
  57. Mazefsky, C. A., McPartland, J. C., Gastgeb, H. Z., & Minshew, N. J. (2013). Brief report: Comparability of DSM-IV and DSM-5 ASD research samples. Journal of Autism and Developmental Disorders, 43, 1236–1242.
  58. McCabe, R., Bullenkamp, J., Hansson, L., Lauber, C., Martinez-Leal, R., Rössler, W., . . . Priebe, S. (2012). The therapeutic relationship and adherence to antipsychotic medication in schizophrenia. PLoS ONE, 7, 1–5. doi:10.1371/journal.pone.0036080
  59. McGuiness, T. M., & Johnson, K. (2013). DSM-5 changes in the diagnosis of autism spectrum disorder. Journal of Psychosocial Nursing, 51(4), 17–19.
  60. McPartland, J. C., Reichaw, B., & Volkmar, F. R., (2012). Sensitivity and specificity of proposed DSM-5 diagnostic criteria for autism spectrum disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 51, 369–383.
  61. Mergl, R., Seidscheck, I., Allgaier, A., Möller, H., Hergerl, U., & Henkel, V. (2007). Depressive, anxiety, and somatoform disorders in primary care: Prevalence and recognition. Depression and Anxiety, 24, 185–195. doi:10.1002/da.20192
  62. Mitchell, A. J. (2013). Redefining the syndrome of cognitive impairment in DSM-5. Australian and New Zealand Journal of Psychiatry, 47, 79–81.
  63. National Alliance on Mental Illness. (2013). PACT: Program of assertive community treatment. Retrieved from http://www.nami.org/Template.cfm?Section=ACT-TA_Center&template=/ContentManagement/ContentDisplay.cfm&ContentID=132547
  64. National Institute of Mental Health. (2009). Schizophrenia (NIH Publication No. 09-3517). Retrieved from http://www.nimh.nih.gov/health/publications/schizophrenia/
  65. National Institute of Mental Health. (2012). Mental health medications (NIH Publication No. 12-3929). Retrieved from http://www.nimh.nih.gov/health/publications/mental-health-medications/nimh-mental-health-medications.pdf
  66. Obiols, J. (2012). DSM 5: Precedents, present and prospects. International Journal of Clinical and Health Psychology, 12, 281–290.
  67. Pagsberg, A. K. (2013). Schizophrenia spectrum and other psychotic disorders. European Child & Adolescent Psychiatry, 22, S3–S9. doi:10.1007/s00787-012-0354-x
  68. Pastor, C. N., & Reuben, C. A. (2008). Diagnosed attention deficit hyperactivity disorder and learning disability: United States 2004–2006. Vital Health Statistics, 10, 1–22.
  69. Pinborough-Zimmerman, J., Bakian, A. V., Fombonne, E., Bilder, D., Taylor, J., & McMahon, W. M. (2012). Changes in the administrative prevalence of autism spectrum disorders: Contribution of special education and health from 2002–2008. Journal of Autism and Developmental Disorders, 42, 521–530.
  70. Potuzak, M., Ravichandran, C., Lewandowski, K. E., Ongür, D., & Cohen, B. M. (2012). Categorical vs dimensional classifications of psychotic disorders. Comprehensive Psychiatry, 53, 1118–1129. doi:10.1016/j.comppsych.2012.04.010
  71. Psychiatric Rehabilitation Consultants. (2011). Products and services for the partners in recovery. Retrieved from www.psychrehab.com
  72. Remington, R. (2012). Neurocognitive diagnostic challenges and the DSM-5: Perspectives from the frontlines of clinical practice. Issues in Mental Health Nursing, 33, 626–629.
  73. Ritsner, M. S., Mar, M., Arbitman, M., & Grinshpoon, A. (2013). Symptom severity scale of the DSM-5 for schizophrenia, and other psychotic disorders: Diagnostic validity and clinical feasibility. Psychiatry Research, 208, 1–8. doi:10.1016/j.psychres.2013.02.029
  74. Rosa's Law, Pub. L. No. 111-256 (2010).
  75. Rössler, W. (2011). Management, rehabilitation, stigma. In W. Gaebel (Ed.), Schizophrenia: Current science and clinical practice (pp. 217–246). Hoboken, NJ: Wiley-Blackwell.
  76. Rubin, A., & Trawver, K. (2011). Overview and clinical implications of schizophrenia. In A. S. Rubin, D. W. Springer, & K. Trawver (Eds.), Psychosocial treatment of schizophrenia: Clinician's guide to evidence-based practice (pp. 1–22). Hoboken, NJ: Wiley-Blackwell.
  77. Sharma, M. P., & Manjula, M. (2013). Behavioural and psychological management of somatic symptom disorders: An overview. International Review of Psychiatry, 25, 116–124. doi:10.3109/09540261.2012.746649
  78. Schizophrenia medications. (2013, March 8). The New York Times. Retrieved from http://health.nytimes.com/health/guides/disease/schizophrenia/medications.html
  79. Simeon, D., Guralnik, O., Schmeidler, J., Sirof, B., & Knutelska, M. (2001). The role of childhood interpersonal trauma in depersonalization disorder. American Journal of Psychiatry, 158, 1027–1033.
  80. Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., & Baird, G. (2008). Psychiatric disorders in children with autism disorders: Prevalence, comorbidity and associated factors in a population-derived sample. Journal of the American Academy of Child & Adolescent Psychiatry, 47, 921–929.
  81. Sirri, L., & Fava, G. A. (2013). Diagnostic criteria for psychosomatic research and somatic symptom disorders. International Review of Psychiatry, 25, 19–30. doi:10.3109/09540261.2012.726923
  82. So, J. K. (2008). Somatization as cultural idiom of distress: Rethinking mind and body in a multicultural society. Counseling Psychology Quarterly, 21, 167–174. doi:10.1080/09515070802066854
  83. Sorrell, J. M. (2013). Diagnostic and statistical manual of mental disorders–5: Implications for older adults and their families. Journal of Psychosocial Nursing, 51(3), 19–22.
  84. Spiegel. D., Loewenstein, R., Lewis- Fernández, R., Sar, V., Simeon, D., Vermetten, E., . . . Dell, P. F. (2011). Dissociative disorders in DSM-5. Depression and Anxiety, 28, 824–852. doi:10.1002/da.20874
  85. Stone, J., LaFrance, W. C., Brown, R., Spiegel, D., Levenson, J. L., & Sharpe, M. (2011). Conversion disorder: Current problems and potential solutions for DSM-5. Journal of Psychosomatic Research, 71, 369–376.
  86. Substance Abuse and Mental Health Services Administration. (2008). Getting started with evidence-based practices: Assertive community treatment (SAMHSA Publication SMA08-4345). Washington, DC: Author.
  87. Substance Abuse and Mental Health Services Administration. (2010). Getting started with evidence-based practices: Family education (SAMHSA Publication SMA09-4423). Washington, DC: Author.
  88. Tandon, R. (2013a). Schizophrenia and other psychotic disorders in DSM-5: Clinical implications of revisions from DSM-IV. Clinical Schizophrenia & Related Psychoses, 7, 16–19.
  89. Tandon, R. (2013b). Schizophrenia spectrum and other psychotic disorders: DSM-5 revisions and their clinical implications. Psychopharm Review, 48, 33–39. doi:10.1097/01.PSYPHR.0000430951.60967.d6
  90. Taylor, S., Asmundson, G. J. G., & Coons, M. J. (2005). Current directions in the treatment of hypochondriasis. Journal of Cognitive Psychotherapy: An International Quarterly, 19, 285–304.
  91. Tófoli, L. F., Andrade, L. H., & Fortes, S. (2011). Somatization in Latin America: A review on the classification and somatoform disorders, functional syndromes, and medically unexplained symptoms. Revista Brasileira de Psiquiatria, 33, 570–580.
  92. Tsai, L. (2012). Sensitivity and specificity: DSM-IV versus DSM-5 criteria for autism spectrum disorder. American Journal of Psychiatry, 169, 1009–1011.
  93. Valencia, M., Juarez, F., & Ortega, H. (2012). Integrated treatment to achieve functional recovery in first-episode psychosis. Schizophrenia Research and Treatment, 2012, Article ID 962371. doi:10.1155/2012/962371
  94. Voigt, K., Wollburg, E., Weinmann, N., Herzog, A., Meyer, B., Langs, G., & Löwe, B. (2012). Predictive validity and clinical utility of DSM-5 somatic symptom disorder: Comparison with DSM-IV somatoform disorders and additional criteria for consideration. Journal of Psychosomatic Research, 73, 345–350. doi:10.1016/j.jpsychores.2012.08.020
  95. Wakefield, J. C. (2013). DSM-5: An overview of changes and controversies. Journal of Clinical Social Work, 41, 139–154.
  96. Walsh, J. (2011). Therapeutic communication with psychotic clients. Clinical Social Work Journal, 39, 1–8.
  97. Weitlauf, A. S., Gotham, K. O., Vehorn, A. C., & Warren, Z. E. (2013). Brief report: DSM-5 “Levels of support”: A comment on discrepant conceptualizations of severity in ASD. Journal of Autism and Developmental Disorder. Advance online publication. doi:10.1007/s10803-013-1882-z
  98. Wilson, C. E., Gillan, N., Spain, D., Robertson, D., Roberts, G., Murphy, C. M., . . . Murphy, D. G. (2013). Comparison of ICD-10R, DSM-IV-TR and DSM-5 in an adult autism spectrum disorder diagnostic clinic. Journal of Autism and Developmental Disorder, 43, 2515–2525. doi:10.1007/s10803-013-1799-6
  99. Wollburg, E., Voigt, K., Braukhaus, C., Herzog, A., & Löwe, B. (2013). Construct validity and descriptive validity of somatoform disorders in light of proposed changes for the DSM-5. Journal of Psychosomatic Research, 74, 18–24. doi:10.1016/j.jpsychores.2012.09.015
  100. World Health Organization. (2007). International statistical classification of diseases and related health problems, 10th revision. Geneva, Switzerland: Author.